课题基金 / 基金详情

项目摘要

项目成果

EDGAR G. ENGLEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Evidence that AIDS may be transmitted by transfusion of blood from asymptomatic members of AIDS high risk groups has prompted a search for a screening test that can be used to identify a carrier state for the disorder. We propose to assess selected alternative assays for their ability to predict the development of AIDS or persistent lymphadenopathy syndrome in a group of homosexual men at increased risk for developing these disorders. We will also study two groups of volunteer blood donors with laboratory findings seen uncommonly in our general donor pool, but known to be significantly more prevalent in patients with AIDS and AIDS related disorder. The populations to be studied serially over 3 years will include 150 apparently healthy homosexual men with multiple anonymous sexual partners, 100 volunteer blood donors with persistent inversions of the ratio of helper/inducer to suppressor/cytotoxic T lymphocytes (Th:Ts), 100 volunteer blood donors with antibodies to the human T cell leukemia/lymphoma viruses (HTLV), and 50 volunteer blood donors with Th:Ts within the normal range. Groups of 5 patients with fully expressed AIDS and 50 with persistent generalized lymphadenopathy will be tested at the beginning of the study only. In addition to clinical follow-up, the following assays will be performed at the initiation of the study and at six month intervals thereafter: analysis of T lymphocyte subsets using a panel of monoclonal antibodies, including several novel reagents; measurement in serum of soluble forms of lympohcyte surface molecules; tests to detect antibodies to the three identified types of human T cell leukemia lymphoma viruses (HTLV); tests of circulating immune complexes; serum levels of beta-2-microglobulin and thymosin alpha-1; and tests for the presence of antibody to hepatitis B core antigen (HBcAb). These assays have been chosen for study on the basis of encouraging preliminary studies and potential ease of methodology. Correlation of the clinical and laboratory findings in the AIDS hight risk and blood donor groups may help to identify the procedure or combination of procedures best able to predict subsequent development of AIDS or related disorders, with potential applications to screening donated blood to detect an AIDS carrier state.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes.
有证据表明 HIV-1 进入 CD4 淋巴细胞需要 T 细胞激活。
DOI: --
发表时间: 1989
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Gowda,SD, Stein,BS, Mohagheghpour,N, Benike,CJ, Engleman,EG]
通讯作者: Engleman,EG
Utility of formaldehyde fixation for flow cytometry and inactivation of the AIDS associated retrovirus.
甲醛固定用于流式细胞术和艾滋病相关逆转录病毒灭活的用途。
DOI: 10.1016/0022-1759(86)90278-4
发表时间: 1986
期刊: Journal of immunological methods
影响因子: 2.2
作者: [Lifson,JD, Sasaki,DT, Engleman,EG]
通讯作者: Engleman,EG
Variables affecting T-lymphocyte subsets in a volunteer blood donor population.
影响志愿者献血者群体中 T 淋巴细胞亚群的变量。
DOI: 10.1016/0090-1229(85)90116-3
发表时间: 1985
期刊: Clinical immunology and immunopathology
影响因子: --
作者: [Lifson,JD, Finch,SL, Sasaki,DT, Engleman,EG]
通讯作者: Engleman,EG
Project 1 Mouse Models Analysis
  • 批准号:
    10729466
  • 项目类别:
  • 资助金额:
    $56.36万
  • 财政年份:
    2023
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
  • 批准号:
    10729464
  • 项目类别:
  • 资助金额:
    $191.91万
  • 财政年份:
    2023
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
  • 批准号:
    10704089
  • 项目类别:
  • 资助金额:
    $42.16万
  • 财政年份:
    2021
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
Targeting Lymph Node Dependent Immune Tolerance in Cancer
  • 批准号:
    10210557
  • 项目类别:
  • 资助金额:
    $53.17万
  • 财政年份:
    2021
  • 负责人:
    EDGAR G. ENGLEMAN
  • 依托单位:
海外基金